Cholangitis screening: Difference between revisions
m (Bot: Removing from Primary care) |
|||
| (7 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Cholangitis}} | {{Cholangitis}} | ||
{{CMG}} {{AE}} {{FH}} | {{CMG}}; {{AE}} {{FH}} | ||
==Overview== | ==Overview== | ||
There are no accepted screening | There are no accepted screening processes for [[cholangitis]] or [[cholangiocarcinoma]], a [[cancer]] associated with this disease. Methods do exist to detect the early onset of both diseases. | ||
==Screening== | ==Screening== | ||
[[ | The cancer predominantly associated with [[cholangitis]] is [[cholangiocarcinoma]]. There are no accepted screening programs for either disease. However, methods for detecting early onsets of cholangitis and cholangiocarcinoma include using [[biochemical markers]], scanning using [[positron emission tomography]] (PET) scan or [[magnetic resonance imaging]] (MRI), and endoscopic procedures such as endosonography and [[endoscopic retrograde cholangiopancreatography]].<ref name="pmid18508979">{{cite journal |vauthors=Kitiyakara T, Chapman RW |title=Chemoprevention and screening in primary sclerosing cholangitis |journal=Postgrad Med J |volume=84 |issue=991 |pages=228–37 |year=2008 |pmid=18508979 |doi=10.1136/pgmj.2007.064592 |url=}}</ref> | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WS}} | |||
{{WH}} | |||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Surgery]] | |||
Latest revision as of 20:55, 29 July 2020
|
Cholangitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cholangitis screening On the Web |
|
American Roentgen Ray Society Images of Cholangitis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farwa Haideri [2]
Overview
There are no accepted screening processes for cholangitis or cholangiocarcinoma, a cancer associated with this disease. Methods do exist to detect the early onset of both diseases.
Screening
The cancer predominantly associated with cholangitis is cholangiocarcinoma. There are no accepted screening programs for either disease. However, methods for detecting early onsets of cholangitis and cholangiocarcinoma include using biochemical markers, scanning using positron emission tomography (PET) scan or magnetic resonance imaging (MRI), and endoscopic procedures such as endosonography and endoscopic retrograde cholangiopancreatography.[1]
References
- ↑ Kitiyakara T, Chapman RW (2008). "Chemoprevention and screening in primary sclerosing cholangitis". Postgrad Med J. 84 (991): 228–37. doi:10.1136/pgmj.2007.064592. PMID 18508979.